Loading clinical trials...
Loading clinical trials...
Study of EOS884448 Alone, and in Combination with Iberdomide with or Without Dexamethasone, in Participants with Relapsed or Refractory Multiple Myeloma
Conditions
Interventions
EOS884448
Iberdomide
+1 more
Locations
13
United States
Banner MD Anderson
Gilbert, Arizona, United States
Eastern Connecticut Hematology & Oncology
Norwich, Connecticut, United States
Hackensack University Medical Center
Hackensack, New Jersey, United States
Fred Hutchinson Cancer Center
Seattle, Washington, United States
ZNA Cadix
Antwerp, Belgium
Institut Jules Bordet
Brussels, Belgium
Start Date
May 1, 2022
Primary Completion Date
November 29, 2023
Completion Date
November 29, 2023
Last Updated
October 26, 2024
NCT07249528
NCT06679101
NCT05969860
NCT06870760
NCT06057402
NCT06383143
Lead Sponsor
iTeos Therapeutics
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions